Company intelligence / Profile preview

Qrono

Pittsburgh, Pennsylvania, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Qrono is developing immunotherapy drugs using the Eloquent platform to activate immune cells against tumors; planned clinical trials as of 2021, no recent updates on results.

Therapeutic areas: OncologyImmunology
Modalities: Immunotherapy
Industry: Biotech

Partnerships

Tufts University Cumming School of Veterinary Medicine

Beyond the preview

Go deeper on Qrono.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qrono.

Explore the full profile